Mark Pines

8.6k total citations
181 papers, 7.0k citations indexed

About

Mark Pines is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Mark Pines has authored 181 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 28 papers in Surgery and 28 papers in Genetics. Recurrent topics in Mark Pines's work include Animal Nutrition and Physiology (20 papers), Muscle Physiology and Disorders (15 papers) and Liver physiology and pathology (14 papers). Mark Pines is often cited by papers focused on Animal Nutrition and Physiology (20 papers), Muscle Physiology and Disorders (15 papers) and Liver physiology and pathology (14 papers). Mark Pines collaborates with scholars based in Israel, United States and Italy. Mark Pines's co-authors include Arnon Nagler, S. Hurwitz, Olga Genina, Orna Halevy, Olga Genin, Peter Gierschik, V. Knopov, Allen M. Spiegel, Efrat Monsonego‐Ornan and Irena Lavelin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Pines

180 papers receiving 6.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Pines 3.2k 905 901 770 758 181 7.0k
Rajendra Raghow 3.3k 1.0× 1.1k 1.2× 607 0.7× 708 0.9× 536 0.7× 128 6.6k
A F Purchio 5.1k 1.6× 544 0.6× 1.6k 1.7× 784 1.0× 1.4k 1.8× 85 8.4k
Mamoru Hasegawa 5.6k 1.8× 954 1.1× 1.8k 2.0× 781 1.0× 765 1.0× 197 8.5k
Michinari Hamaguchi 6.3k 2.0× 663 0.7× 1.1k 1.2× 1.4k 1.8× 1.7k 2.3× 214 10.6k
J.H. Veerkamp 4.5k 1.4× 680 0.8× 726 0.8× 359 0.5× 460 0.6× 203 8.1k
Paul H. Weigel 5.0k 1.6× 668 0.7× 429 0.5× 622 0.8× 651 0.9× 166 8.0k
Margit Mahlapuu 3.8k 1.2× 668 0.7× 487 0.5× 548 0.7× 247 0.3× 72 5.8k
Carol Basbaum 3.6k 1.1× 750 0.8× 393 0.4× 1.5k 2.0× 1.0k 1.4× 131 8.1k
James P. Quigley 5.5k 1.7× 725 0.8× 779 0.9× 2.0k 2.6× 3.8k 5.0× 119 12.5k
Jun Nakayama 4.7k 1.5× 1.8k 2.0× 442 0.5× 2.4k 3.1× 869 1.1× 265 8.2k

Countries citing papers authored by Mark Pines

Since Specialization
Citations

This map shows the geographic impact of Mark Pines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pines more than expected).

Fields of papers citing papers by Mark Pines

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pines. The network helps show where Mark Pines may publish in the future.

Co-authorship network of co-authors of Mark Pines

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pines. A scholar is included among the top collaborators of Mark Pines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pines. Mark Pines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Genin, Olga, et al.. (2020). Early pathological signs in young dysf mice are improved by halofuginone. Neuromuscular Disorders. 30(6). 472–482. 4 indexed citations
2.
Pines, Mark, et al.. (2015). Halofuginone promotes satellite cell activation and survival in muscular dystrophies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(1). 1–11. 15 indexed citations
3.
Pines, Mark, et al.. (2014). Halofuginone improves muscle-cell survival in muscular dystrophies. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(7). 1339–1347. 21 indexed citations
4.
Genin, Olga, A. Hasdai, D. Shinder, & Mark Pines. (2012). The effect of inhibition of heat-shock proteins on thiram-induced tibial dyschondroplasia. Poultry Science. 91(7). 1619–1626. 32 indexed citations
5.
Zilberstein, Yael, et al.. (2012). The Involvement of Collagen Triple Helix Repeat Containing 1 in Muscular Dystrophies. American Journal Of Pathology. 182(3). 905–916. 13 indexed citations
6.
Pines, Mark, et al.. (2010). Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: Effect on myotube fusion. Experimental Cell Research. 316(6). 1061–1069. 63 indexed citations
7.
Har‐Shai, Yaron, et al.. (2010). Keloid histopathology after intralesional cryosurgery treatment. Journal of the European Academy of Dermatology and Venereology. 25(9). 1027–1036. 37 indexed citations
8.
Pines, Mark. (2007). Targeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone. Expert Opinion on Drug Discovery. 3(1). 11–20. 40 indexed citations
9.
Taras, Danièle, Jean‐Frédéric Blanc, Anne Rullier, et al.. (2006). Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition. Neoplasia. 8(4). 312–318. 33 indexed citations
10.
Eliashar, Ron, et al.. (2006). Halofuginone Prevents Subglottic Stenosis in a Canine Model. Annals of Otology Rhinology & Laryngology. 115(5). 382–386. 15 indexed citations
11.
Pinthus, Jehonathan H., Arnon Nagler, Eddie Fridman, et al.. (2005). INHIBITION OF WILMS TUMOR XENOGRAFT PROGRESSION BY HALOFUGINONE IS ACCOMPANIED BY ACTIVATION OF WT-1 GENE EXPRESSION. The Journal of Urology. 174(4 Part 2). 1527–1531. 25 indexed citations
12.
Blank, Miri, Yair Levy, Howard Amital, et al.. (2002). The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice. Arthritis & Rheumatism. 46(6). 1689–1690. 54 indexed citations
13.
Bar, Arie, et al.. (1998). Regulation of Osteopontin Gene Expression During Egg Shell Formation in the Laying Hen by Mechanical Strain. Matrix Biology. 17(8-9). 615–623. 46 indexed citations
14.
Nagler, Arnon, et al.. (1996). Reduction in Pulmonary Fibrosis in Vivo by Halofuginone. American Journal of Respiratory and Critical Care Medicine. 154(4). 1082–1086. 66 indexed citations
15.
Levi‐Schaffer, Francesca, et al.. (1996). Inhibition of Collagen Synthesis and Changes in Skin Morphology in Murine Graft-Versus-Host Disease and Tight Skin Mice: Effect of Halofuginone. Journal of Investigative Dermatology. 106(1). 84–88. 61 indexed citations
16.
Pines, Mark, et al.. (1995). The involvement of the epiphyseal growth plate in longitudinal bone growth and in tibial dyschondroplasia. Archiv für Geflügelkunde. 59. 28–30. 1 indexed citations
18.
Granot, Irit, Mark Pines, I. Plavnik, et al.. (1991). Skin Tearing in Broilers in Relation to Skin Collagen: Effect of Sex, Strain, and Diet. Poultry Science. 70(9). 1928–1935. 33 indexed citations
19.
Rosenberg, Jacob, Mark Pines, Jay J. Levy, et al.. (1989). Renal and Adrenal Adenosine 3′,5′-Monophosphate Production and Corticosteroid Secretion in Response to Synthetic Chicken Parathyroid Hormone-(1–34)*. Endocrinology. 125(2). 1082–1089. 7 indexed citations
20.
Gierschik, Peter, et al.. (1988). Immunochemical studies of the 36-kDa common beta subunit of guanine nucleotide-binding proteins: identification of a major epitope.. Molecular Pharmacology. 33(3). 257–264. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026